Organoids generated in animal-free media show scalable outcomes compared to xeno-cultures.

Cells cultured in a xeno-free GMP-grade condition can minimize lot-to-lot variability. Xeno-free serum substitute can also lead to higher PBMC-derived T-cell expansion.

Automated Preclinical research testing with prostate cancer organoids to accelerate drug development.